Press Releases
Proniras Corporation Announces First Patient Enrolled in Phase 1 Clinical Trial for Opioid Withdrawal Syndrome
November 14, 2024
Proniras Corporation Secures New Series B Financing and Names New Board Members to Support Phase 1 Study of Novel Treatment for Opiate Withdrawal
February 01, 2024